losartan has been researched along with ularitide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahlmann, L; Heringlake, M; Klaus, S; Pagel, H; Schmucker, P; Wagner, K | 1 |
| Carstens, J; Pedersen, EB | 1 |
1 trial(s) available for losartan and ularitide
| Article | Year |
|---|---|
Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
Topics: Adult; Aldosterone; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic GMP; Diuresis; Diuretics; Glomerular Filtration Rate; Heart Rate; Hematocrit; Humans; Indomethacin; Kidney; Kidney Function Tests; Lithium; Losartan; Male; Natriuresis; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Receptors, Angiotensin; Renal Plasma Flow, Effective; Renin; Single-Blind Method | 2008 |
1 other study(ies) available for losartan and ularitide
| Article | Year |
|---|---|
Effects of angiotensin II and the AT(1) receptor antagonist losartan on the renal excretion of urodilatin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Endothelin-1; Glomerular Filtration Rate; Kidney; Losartan; Male; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Sodium; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |